Unveiling the Mystery of MEN1 Phenocopies: A National Study's Surprising Findings
The enigma of MEN1 phenocopies: Multiple endocrine neoplasia type 1 (MEN1) is a genetic disorder, yet some patients with MEN1-like symptoms lack the expected gene mutations, puzzling doctors and researchers. This multicentric study across Italy aimed to shed light on this clinical conundrum.
Study Overview:
- Publication Date: November 12, 2025
- Study Type: Multicentric national retrospective study
- Objective: To characterize MEN1 phenocopies, a subset of patients with MEN1-like symptoms but no identifiable MEN1 mutations.
- Authors: Ruggeri, Benevento, Hasballa, and others, representing the NIKE Group
The Study's Findings:
- Out of 240 suspected MEN1 patients, 175 had confirmed MEN1 mutations, while 65 (27%) were phenocopies.
- Phenocopies were diagnosed significantly later than MEN1 patients, often by one to two decades.
- Primary hyperparathyroidism (PHPT) was prevalent in both groups, but tumor associations varied. The classic MEN1 triad was rare in phenocopies, while PHPT with pituitary neuroendocrine tumors (PitNETs) was more common, resembling sporadic tumor patterns.
- Interestingly, 11% of phenocopies had a first-degree relative with MEN1-related diseases, and over half had a personal or family history of cancer.
Clinical Implications:
MEN1 phenocopies are more common than previously thought, posing a diagnostic challenge. Given their unique clinical and familial profiles, an extended genetic panel and periodic screening for MEN1-related diseases are recommended for these patients. But here's where it gets controversial—should these tests be offered to all patients with MEN1-like symptoms, or only those with certain risk factors? And what are the ethical considerations when it comes to genetic testing and screening?
Access the Full Study:
The original article is available in the Journal of Endocrinological Investigation, providing a comprehensive analysis of this intriguing topic.
Upcoming Webinar:
Don't miss the live webinar on colorectal cancer (CRC) advancements, featuring renowned experts. Stay updated with the latest research and its impact on patient care.
Date: December 11, 2025
Time: 18:00-19:30 (CET)
Speakers: Prof. Antoni Castells and Prof. Edward Giovannucci
Register Now: [Webinar Link]
ESMO Congress Hub:
Explore exclusive content from the European Society for Medical Oncology's annual congress, including expert interviews and the latest oncology news.
Access: [ESMO Congress Link]
Image Credits:
- Colon cancer illustration: © (M) KATERYNA KON/SCIENCE PHOTO LIBRARY / Getty Images
- Cancer cell screening concept: © artacet / iStock / Getty Images Plus
- Human brain illustration: © (M) CHRISTOPH BURGSTEDT / SCIENCE PHOTO LIBRARY / Getty Images
